Schedule 13G ownership disclosure
ESSA PHARMA INC
Security class unavailable · CUSIP: 29668H708
Event date: 2024-11-01
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 0.0000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-24-258982
- Form type
- SC 13G
- Filer
- BB BIOTECH AG
- CIK
- CIK 924223
- Filed
- Nov 14, 2024
- Reporting period
- Nov 01, 2024
- Description
- Schedule 13G beneficial ownership